141 related articles for article (PubMed ID: 37935336)
1. Association between regular proton pump inhibitors use and cardiovascular outcomes: A large prospective cohort study.
Li ZH; Zhong WF; Qiu CS; Yang P; Song WQ; Shen D; Zhang XR; Liu D; Chen YJ; Chen PL; Huang QM; Chen Q; Wang XM; Chung VCH; Gao X; Kraus VB; Liu SD; Mao C
Int J Cardiol; 2024 Jan; 395():131567. PubMed ID: 37935336
[TBL] [Abstract][Full Text] [Related]
2. Associations of Menstrual Cycle Regularity and Length With Cardiovascular Diseases: A Prospective Study From UK Biobank.
Huang C; Lin B; Yuan Y; Li K; Xu B; Zhang P; Wei X; Wang W; Liu W; Deng Y; Liu D; Lin J; Huang Y; Zhang H
J Am Heart Assoc; 2023 Jun; 12(11):e029020. PubMed ID: 37222132
[TBL] [Abstract][Full Text] [Related]
3. Proton Pump Inhibitor Use, Hypomagnesemia and Risk of Cardiovascular Diseases: The Atherosclerosis Risk in Communities (ARIC) Study.
Rooney MR; Bell EJ; Alonso A; Pankow JS; Demmer RT; Rudser KD; Chen LY; Lutsey PL
J Clin Gastroenterol; 2021 Sep; 55(8):677-683. PubMed ID: 33471493
[TBL] [Abstract][Full Text] [Related]
4. Association Between Depressive Symptoms and Incident Cardiovascular Diseases.
Harshfield EL; Pennells L; Schwartz JE; Willeit P; Kaptoge S; Bell S; Shaffer JA; Bolton T; Spackman S; Wassertheil-Smoller S; Kee F; Amouyel P; Shea SJ; Kuller LH; Kauhanen J; van Zutphen EM; Blazer DG; Krumholz H; Nietert PJ; Kromhout D; Laughlin G; Berkman L; Wallace RB; Simons LA; Dennison EM; Barr ELM; Meyer HE; Wood AM; Danesh J; Di Angelantonio E; Davidson KW;
JAMA; 2020 Dec; 324(23):2396-2405. PubMed ID: 33320224
[TBL] [Abstract][Full Text] [Related]
5. Association of Proton Pump Inhibitors With Higher Risk of Cardiovascular Disease and Heart Failure.
Bell EJ; Bielinski SJ; St Sauver JL; Chen LY; Rooney MR; Larson NB; Takahashi PY; Folsom AR
Mayo Clin Proc; 2021 Oct; 96(10):2540-2549. PubMed ID: 34607633
[TBL] [Abstract][Full Text] [Related]
6. Regular use of proton-pump inhibitors and risk of stroke: a population-based cohort study and meta-analysis of randomized-controlled trials.
Yang M; He Q; Gao F; Nirantharakumar K; Veenith T; Qin X; Page AT; Wong MCS; Huang J; Kuo ZC; Xia B; Zhang C; He Y; Meng W; Yuan J; Pan Y
BMC Med; 2021 Dec; 19(1):316. PubMed ID: 34856983
[TBL] [Abstract][Full Text] [Related]
7. Regular Use of Proton Pump Inhibitor and the Risk of Inflammatory Bowel Disease: Pooled Analysis of 3 Prospective Cohorts.
Xia B; Yang M; Nguyen LH; He Q; Zhen J; Yu Y; Di M; Qin X; Lu K; Kuo ZC; He Y; Zhang C; Meng W; Yuan J
Gastroenterology; 2021 Dec; 161(6):1842-1852.e10. PubMed ID: 34389338
[TBL] [Abstract][Full Text] [Related]
8. Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study.
Mark PB; Carrero JJ; Matsushita K; Sang Y; Ballew SH; Grams ME; Coresh J; Surapaneni A; Brunskill NJ; Chalmers J; Chan L; Chang AR; Chinnadurai R; Chodick G; Cirillo M; de Zeeuw D; Evans M; Garg AX; Gutierrez OM; Heerspink HJL; Heine GH; Herrington WG; Ishigami J; Kronenberg F; Lee JY; Levin A; Major RW; Marks A; Nadkarni GN; Naimark DMJ; Nowak C; Rahman M; Sabanayagam C; Sarnak M; Sawhney S; Schneider MP; Shalev V; Shin JI; Siddiqui MK; Stempniewicz N; Sumida K; Valdivielso JM; van den Brand J; Yee-Moon Wang A; Wheeler DC; Zhang L; Visseren FLJ; Stengel B
Eur Heart J; 2023 Apr; 44(13):1157-1166. PubMed ID: 36691956
[TBL] [Abstract][Full Text] [Related]
9. Proton Pump Inhibitor Use and the Risk of Cardiovascular Complications and Death in Older Adults with Diabetes: A Population-Based Cohort Study.
Foresta A; Fernandez LO; Torrigiani G; Schena S; Roncaglioni MC; Nobili A; Tettamanti M; Franchi C; Fortino I; Succurro E; Sesti G; Baviera M
Drugs Aging; 2024 Mar; 41(3):239-249. PubMed ID: 38367169
[TBL] [Abstract][Full Text] [Related]
10. Adult height and risk of ischemic heart disease, atrial fibrillation, stroke, venous thromboembolism, and premature death: a population based 36-year follow-up study.
Schmidt M; Bøtker HE; Pedersen L; Sørensen HT
Eur J Epidemiol; 2014 Feb; 29(2):111-8. PubMed ID: 24337942
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Bansal N; Xie D; Sha D; Appel LJ; Deo R; Feldman HI; He J; Jamerson K; Kusek JW; Messe S; Navaneethan SD; Rahman M; Ricardo AC; Soliman EZ; Townsend R; Go AS
J Am Soc Nephrol; 2018 Dec; 29(12):2859-2869. PubMed ID: 30377231
[TBL] [Abstract][Full Text] [Related]
12. Migraine and risk of cardiovascular diseases: Danish population based matched cohort study.
Adelborg K; Szépligeti SK; Holland-Bill L; Ehrenstein V; Horváth-Puhó E; Henderson VW; Sørensen HT
BMJ; 2018 Jan; 360():k96. PubMed ID: 29386181
[TBL] [Abstract][Full Text] [Related]
13. Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies.
Yuan J; He Q; Nguyen LH; Wong MCS; Huang J; Yu Y; Xia B; Tang Y; He Y; Zhang C
Gut; 2021 Jun; 70(6):1070-1077. PubMed ID: 32989021
[TBL] [Abstract][Full Text] [Related]
14. Acid suppressants use and risk of atherosclerotic cardiovascular disease in middle-aged and older adults.
Ma Y; Li S; Yang H; Zhang Y; Li H; Zhou L; Lin J; Chen Y; Hou Y; Zhang X; Liu T; Zhou X; Wang Y
Atherosclerosis; 2022 Oct; 358():47-54. PubMed ID: 36113328
[TBL] [Abstract][Full Text] [Related]
15. β-Thromboglobulin and incident cardiovascular disease risk: The Atherosclerosis Risk in Communities study.
Kubota Y; Alonso A; Folsom AR
Thromb Res; 2017 Jul; 155():116-120. PubMed ID: 28531882
[TBL] [Abstract][Full Text] [Related]
16. Fatty Liver Index as a proxy for non-alcoholic fatty liver disease and the risk of stroke and coronary heart disease: The Suita Study.
Arafa A; Kashima R; Matsumoto C; Kokubo Y
J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107495. PubMed ID: 38000108
[TBL] [Abstract][Full Text] [Related]
17. Risk of circulatory diseases associated with proton-pump inhibitors: a retrospective cohort study using electronic medical records in Thailand.
Pannoi T; Promchai C; Apiromruck P; Wongpraphairot S; Dong YH; Yang CC; Pan WC
PeerJ; 2024; 12():e16892. PubMed ID: 38371380
[TBL] [Abstract][Full Text] [Related]
18. Proton Pump Inhibitor Use and Risks of Cardiovascular Disease and Mortality in Patients With Type 2 Diabetes.
Geng T; Chen JX; Zhou YF; Lu Q; Wan Z; Liu L; Pan A; Liu G
J Clin Endocrinol Metab; 2023 May; 108(6):e216-e222. PubMed ID: 36573284
[TBL] [Abstract][Full Text] [Related]
19. Regular proton pump inhibitor use and incident dementia: population-based cohort study.
Zhang P; Li Z; Chen P; Zhang A; Zeng Y; Zhang X; Huang Q; Liu D; Qi S; Mao C
BMC Med; 2022 Sep; 20(1):271. PubMed ID: 36045363
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
Tsai YW; Wen YW; Huang WF; Chen PF; Kuo KN; Hsiao FY
J Gastroenterol; 2011 Jan; 46(1):39-45. PubMed ID: 20811753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
